Kamada Pharmaceuticals Competitors and Similar CompaniesClear all
Kamada Pharmaceuticals's competitors and similar companies include Travere Therapeutics, GBT (Global Blood Therapeutics), JCR Pharmaceuticals and Heron Therapeutics.
 Kamada Pharmaceuticals Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications. |  Travere Therapeutics Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases. |  GBT (Global Blood Therapeutics) GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. |  JCR Pharmaceuticals JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products. |  Heron Therapeutics Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development. | |
Founding Date | Founding Date 1990 | Founding Date 2011 | Founding Date 2012 | Founding Date 1975 | Founding Date 1983 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Rehovot, IL HQ Beit Kama, IL | Locations San Diego, US HQ Dublin, IE | Locations South San Francisco, US HQ Paris, FR Berlin, DE Baar, CH London, GB | Locations Ashiya, JP HQ Kobe, JP Kobe, JP Kobe, JP Kobe, JP | Locations San Diego, US HQ |
Employees | Employees 420 | Employees 46293% increase | Employees 352106% increase | Employees 934 | Employees 20333% decrease |
Valuation ($) | Valuation ($) 317 m | Valuation ($) 1.4 b | Valuation ($) 4.4 b | Valuation ($) 533.9 m | Valuation ($) 268.5 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $180.5m (FY, 2025) | Revenue (est.) $490.7m (FY, 2025) | Revenue (est.) $194.7m (FY, 2021) | Revenue (est.) ¥33.1b (FY, 2025) | Revenue (est.) $154.9m (FY, 2025) |
Cost of goods | Cost of goods $72.1m (FY, 2025) | Cost of goods $10.3m (FY, 2025) | Cost of goods $3.3m (FY, 2021) | Cost of goods ¥8b (FY, 2025) | Cost of goods $41.3m (FY, 2025) |
Gross profit | Gross profit $108.4m (FY, 2025) | Gross profit $480.4m (FY, 2025) | Gross profit N/A | Gross profit ¥25.1b (FY, 2025) | Gross profit $113.6m (FY, 2025) |
Net income | Net income $20.2m (FY, 2025) | Net income ($25.5m) (FY, 2025) | Net income ($303.1m) (FY, 2021) | Net income (¥4.7b) (FY, 2025) | Net income ($20.2m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 90m | Total funding raised $ 25m | Total funding raised $ 88.7m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Travere Therapeutics
HQ
San Diego, US
Employees
462
Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
View companyGBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
View companyJCR Pharmaceuticals
HQ
Ashiya, JP
Employees
934
JCR Pharmaceuticals is a company that specializes in the development of pharmaceutical products.
View companyHeron Therapeutics
HQ
San Diego, US
Employees
203↓ 33% decrease
Heron Therapeutics (formerly A.P. Pharma) is a biotechnology company engaged in drug discovery and development.
View company